Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2021
[Interleukin-34: a key molecule in the tumor microenvironment]Nabeel Kajihara, Ken-Ichiro SeinoBritish Journal of Cancer|August 3, 2023
Blocking of oestrogen signals improves anti-tumour effect regardless of oestrogen receptor alpha expression in cancer cellsNabeel Kajihara, Yunqi Ge, Ken-Ichiro SeinoBreast Cancer (Tokyo, Japan)|June 25, 2020
Interleukin-34 contributes to poor prognosis in triple-negative breast cancerNabeel Kajihara, Fumihito Kitagawa, Takuto Kobayashi, et al.Journal of Gynecologic Oncology|January 5, 2023
Interleukin-34 cancels anti-tumor immunity by PARP inhibitorTakayoshi Nakamura, Nabeel Kajihara, Naoki Hama, et al.Cancer Immunology, Immunotherapy : CII|September 14, 2022
Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancerNabeel Kajihara, Takuto Kobayashi, Ryo Otsuka, et al.Oncoimmunology|May 26, 2023
Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cellsNabeel Kajihara, Yoshino Tanaka, Riko Takeuchi, et al.Iscience|January 14, 2022
Erratum: Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint BlockadeNaoki Hama, Takuto Kobayashi, Nanumi Han, et al.Iscience|November 18, 2020
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint BlockadeNaoki Hama, Takuto Kobayashi, Nanumi Han, et al.Pageof 1